# Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer

> **NCT03399071** · PHASE2 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 44 (actual)

## Conditions studied

- Gastric Adenocarcinoma
- Oesophageal Adenocarcinoma

## Interventions

- **DRUG:** FLOT-A

## Key facts

- **NCT ID:** NCT03399071
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-31
- **Primary completion:** 2022-11-01
- **Final completion:** 2025-08-15
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03399071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03399071, "Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03399071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*